Oct. 15 meeting to discuss proposed biosafety lab
ARGONNE, Ill. (Oct. 9, 2003) Representatives from the University
of Chicago and Argonne National Laboratory will speak and be available
to answer questions from the public on plans for a recently-funded
facility for research on infectious diseases. The public meeting
is planned for Wednesday, Oct. 15, at 7 p.m. at Ashton Place, 341
75th Street, Willowbrook, Ill.
The facility, a $30 million Regional
Biocontainment Laboratory, is funded by the National
Institutes of Health and will be located on the Argonne site.
The laboratory is designed for research to fight emerging and
re-emerging infectious diseases and microbes that might be used
in bioterrorism. The scope of the biosafety laboratory's research
will be broad, encompassing emerging diseases such as West Nile
Fever and drug-resistant tuberculosis along with influenza, plague
and other perennial threats to human health.
The research would develop diagnostics, prevention, therapy and
cures of diseases, and would not be involved in developing biological
weapons.
The laboratory will support the Midwest Regional Center of Excellence,
a consortium of 14 research organizations in the Midwest, coordinated
by the University of Chicago and including Argonne, the Mayo Clinic,
and medical schools in Illinois, Indiana, Wisconsin and Michigan.
Representatives at the meeting will include Olaf Schneewind, professor
of molecular genetics and cell biology at the University of Chicago
and director of the Midwest Regional Center of Excellence; and
Harvey Drucker, associate laboratory director at Argonne.
The nations first national laboratory, Argonne National
Laboratory conducts basic and applied scientific research across
a wide spectrum of disciplines, ranging from high-energy physics
to climatology and biotechnology. Since 1990, Argonne has worked
with more than 600 companies and numerous federal agencies and
other organizations to help advance America's scientific leadership
and prepare the nation for the future. Argonne is operated by the University
of Chicago for the U.S. Department
of Energy's Office of Science.
For more information, please contact Catherine Foster (630/252-5580
or cfoster@anl.gov) at Argonne.
|